| Great Basin Urgent Care Llc | |
|
1201 S Main St Ste 110 Logan UT 84322-2600 | |
| (480) 547-9256 | |
| Not Available |
| Full Name | Great Basin Urgent Care Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1201 S Main St Ste 110, Logan, Utah |
| Authorized Official Name and Position | Christopher Sessions (MANAGER) |
| Authorized Official Contact | 4352133046 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Great Basin Urgent Care Llc 1201 S Main St Ste 110 Logan UT 84321-8504 Ph: (435) 213-3046 | Great Basin Urgent Care Llc 1201 S Main St Ste 110 Logan UT 84322-2600 Ph: (480) 547-9256 |
| NPI Number | 1366022444 |
|---|---|
| Provider Enumeration Date | 04/12/2021 |
| Last Update Date | 01/27/2023 |
| Medicare PECOS PAC ID | 9032516893 |
|---|---|
| Medicare Enrollment ID | O20211111000752 |
News Archive
Alcohol impairs everything - from judgment, to reflexes, to balance, making one prone to serious injury .... and who wants to celebrate Thanksgiving in the emergency department- or if you're lucky enough to make it home alive- with a hangover?" says Thomas Esposito, chief of the Division of Trauma, Surgical Critical Care and Burns in the Department of Surgery at Loyola University Medical Center.
A recent paper published in the Journal of Glaucoma shows a new visual evoked potential (VEP) technique to be a fast, objective method to screen for functional damage in glaucomatous eyes.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH's full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi's offerings in the rapidly growing digital pathology market.
Vanguard Health Systems, Inc. ("Vanguard") announced today that in connection with the previously announced tender offers and consent solicitations (the "Tender Offers" and "Consent Solicitations") by Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Health Holding Company I, LLC ("VHS Holdco I"), the extended early tender period in respect of each of the Tender Offers expired at 5:00 p.m., New York City time, on January 29, 2010 (the "New Consent Payment Deadline").
Oxygen Biotherapeutics, Inc., ("OBI") (NASDAQ: OXBT), today announced enrollment of the first subject in the second cohort of its global Phase IIb clinical trial to investigate the safety and tolerability of Oxycyte® in patients with severe, non-penetrating traumatic brain injury ("STOP-TBI").
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366022444 | NPI | - | NPPES |
| Provider Name | Christopher J Morgan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245550268 PECOS PAC ID: 5193983369 Enrollment ID: I20120220000126 |
News Archive
Alcohol impairs everything - from judgment, to reflexes, to balance, making one prone to serious injury .... and who wants to celebrate Thanksgiving in the emergency department- or if you're lucky enough to make it home alive- with a hangover?" says Thomas Esposito, chief of the Division of Trauma, Surgical Critical Care and Burns in the Department of Surgery at Loyola University Medical Center.
A recent paper published in the Journal of Glaucoma shows a new visual evoked potential (VEP) technique to be a fast, objective method to screen for functional damage in glaucomatous eyes.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH's full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi's offerings in the rapidly growing digital pathology market.
Vanguard Health Systems, Inc. ("Vanguard") announced today that in connection with the previously announced tender offers and consent solicitations (the "Tender Offers" and "Consent Solicitations") by Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Health Holding Company I, LLC ("VHS Holdco I"), the extended early tender period in respect of each of the Tender Offers expired at 5:00 p.m., New York City time, on January 29, 2010 (the "New Consent Payment Deadline").
Oxygen Biotherapeutics, Inc., ("OBI") (NASDAQ: OXBT), today announced enrollment of the first subject in the second cohort of its global Phase IIb clinical trial to investigate the safety and tolerability of Oxycyte® in patients with severe, non-penetrating traumatic brain injury ("STOP-TBI").
› Verified 5 days ago
| Provider Name | Terin Renee Sessions |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1427832849 PECOS PAC ID: 7315336435 Enrollment ID: I20231009002369 |
News Archive
Alcohol impairs everything - from judgment, to reflexes, to balance, making one prone to serious injury .... and who wants to celebrate Thanksgiving in the emergency department- or if you're lucky enough to make it home alive- with a hangover?" says Thomas Esposito, chief of the Division of Trauma, Surgical Critical Care and Burns in the Department of Surgery at Loyola University Medical Center.
A recent paper published in the Journal of Glaucoma shows a new visual evoked potential (VEP) technique to be a fast, objective method to screen for functional damage in glaucomatous eyes.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH's full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi's offerings in the rapidly growing digital pathology market.
Vanguard Health Systems, Inc. ("Vanguard") announced today that in connection with the previously announced tender offers and consent solicitations (the "Tender Offers" and "Consent Solicitations") by Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Health Holding Company I, LLC ("VHS Holdco I"), the extended early tender period in respect of each of the Tender Offers expired at 5:00 p.m., New York City time, on January 29, 2010 (the "New Consent Payment Deadline").
Oxygen Biotherapeutics, Inc., ("OBI") (NASDAQ: OXBT), today announced enrollment of the first subject in the second cohort of its global Phase IIb clinical trial to investigate the safety and tolerability of Oxycyte® in patients with severe, non-penetrating traumatic brain injury ("STOP-TBI").
› Verified 5 days ago
News Archive
Alcohol impairs everything - from judgment, to reflexes, to balance, making one prone to serious injury .... and who wants to celebrate Thanksgiving in the emergency department- or if you're lucky enough to make it home alive- with a hangover?" says Thomas Esposito, chief of the Division of Trauma, Surgical Critical Care and Burns in the Department of Surgery at Loyola University Medical Center.
A recent paper published in the Journal of Glaucoma shows a new visual evoked potential (VEP) technique to be a fast, objective method to screen for functional damage in glaucomatous eyes.
Cambridge Research & Instrumentation, Inc. (CRi), a leader in pre-clinical and molecular imaging, announced today that it has signed exclusive agreements to distribute 3DHISTECH's full suite of digital slide scanners and software applications in North America, and the development and distribution of next generation product offerings that address growing applications in digital pathology. These agreements expand CRi's offerings in the rapidly growing digital pathology market.
Vanguard Health Systems, Inc. ("Vanguard") announced today that in connection with the previously announced tender offers and consent solicitations (the "Tender Offers" and "Consent Solicitations") by Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Health Holding Company I, LLC ("VHS Holdco I"), the extended early tender period in respect of each of the Tender Offers expired at 5:00 p.m., New York City time, on January 29, 2010 (the "New Consent Payment Deadline").
Oxygen Biotherapeutics, Inc., ("OBI") (NASDAQ: OXBT), today announced enrollment of the first subject in the second cohort of its global Phase IIb clinical trial to investigate the safety and tolerability of Oxycyte® in patients with severe, non-penetrating traumatic brain injury ("STOP-TBI").
› Verified 5 days ago
Logan Cancer Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1281 N 600 E, Logan, UT 84341 Phone: 435-716-1130 | |
Mtchc Logan Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 550 E 1400 N Ste Xy, Logan, UT 84341 Phone: 801-393-5355 Fax: 801-394-4609 | |
Child And Family Eye Care Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 981 S Main St Ste 220, Logan, UT 84321 Phone: 435-363-2980 Fax: 435-514-0075 | |
Bridge Utah Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1015 E 100 N, Logan, UT 84321 Phone: 888-221-0423 Fax: 888-221-9816 | |
Cache Vein Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1219 N 400 E, Logan, UT 84341 Phone: 435-753-2842 | |
Mountain View Foot And Ankle Specialists Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2310 N 400 E Ste A, Logan, UT 84341 Phone: 435-787-2000 Fax: 435-787-1913 | |
Budge Clinic Anticoagulation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-752-0422 |